The number of deaths caused by heart disease has decreased in the United States from 321.8 per 100,000 population in 1990 to 161.5 deaths per 100,000 population in 2019. Nevertheless, heart disease is still the leading cause of death in the country, followed closely by cancer, which has a mortality rate of 146.2 per 100,000 people.

Heart disease in the U.S.

Diseases of the heart and blood vessels are often associated with atherosclerosis which occurs when plaque builds up along arterial walls. This can limit the flow of blood and can lead to blood clots, a common cause of stroke or heart attacks. Other types of heart disease include arrhythmia (abnormal heart rhythms) and heart valve problems. Many of these diseases can be treated with medication, although many complications will still remain. One of the leading cholesterol lowering drugs in the United States, Crestor, generated around 1.2 billion U.S. dollars of revenue in 2021.

Risk Factors for heart disease There are many risk factors associated with the development of heart disease including family history, ethnicity, and age. However, there are other factors that can be modified through lifestyle changes such as physical inactivity, smoking, and unhealthy diets. Obesity has also been commonly associated with risk factors like hypertension and diabetes type II. In the U.S., some 30 percent of white adults are currently obese.

In 2021, South Korea had the lowest rate of death from ischemic heart disease among OECD countries, with around 28 deaths per 100,000 inhabitants. In comparison, there were around 395 deaths due to ischemic heart disease per 100,000 population in Lithuania. Cardiovascular disease worldwide Fatty deposits accumulating in the inner wall of the coronary artery which restrict blood flow to the heart cause ischemic heart disease (IHD) and can also precipitate heart attacks and strokes. Cardiovascular risk factors such as smoking, heavy alcohol use, and unhealthy diet are more prevalent in Eastern European countries, contributing to a much higher burden of cardiovascular diseases and deaths. In Russia, the general public greatly underestimates the burden of cardiovascular diseases with the actual number of deaths over 40 percent higher than what people estimate. Prevention and intervention Invasive interventions for heart disease can include surgical procedures such as heart bypass surgery- where blood is diverted around clogged parts of major arteries- which ranges in cost around the world. Other medical interventions include the use of prescribed or over-the-counter drugs, such as prescription nitrates or beta blockers, or OTC medications like aspirin. Lifestyle factors to lower blood pressure and cholesterol levels can help decrease risk of heart attacks and other cardiovascular diseases, including maintaining a healthy diet, regular physical activity, and smoking and alcohol cessation.

2019–2020. The National Health Interview Survey (NHIS) has monitored the health of the nation since 1957. NHIS data on a broad range of health topics are collected through personal household interviews. Indicators for this dataset has been computed by personnel in CDC's Division for Heart Disease and Stroke Prevention (DHDSP). This was one of the datasets provided by the National Cardiovascular Disease Surveillance System and presented on DHDSP’s Data, Trends, and Maps online tool. This tool was retired in April of 2024 and this dataset will not be updated. Contact dhdsprequests@cdc.gov if you need assistance with data previously included in this dataset. The data are organized by location (region) and indicator, and they include CVDs (e.g., heart failure) and risk factors (e.g., hypertension). The data can be plotted as trends and stratified by age group, sex, and race/ethnicity.

According to Cognitive Market Research, the global Cardiovascular Information System market size is USD 1.3 billion in 2024 and will expand at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2031. Market Dynamics of Cardiovascular Information System Market

Key Drivers for Cardiovascular Information System Market

Rising Rate of Cardiovascular Illnesses- One of the main reasons the Cardiovascular Information System market is growing is the rising rate of cardiovascular illnesses. The rising frequency of cardiovascular disorders due to fast-paced lives and stress-related problems is predicted to drive up demand for cardiovascular information systems. Cardiovascular disorders account for the vast majority of deaths worldwide. According to a World Health Organization (WHO) estimate issued in 2019, 17.9 million deaths, or 32% of Cardiovascular diseases, were the leading cause of mortality worldwide. In 85% of these cases, a heart attack or stroke caused death. Heart attacks and strokes cause more than four out of every five CVD deaths, with one-third of fatalities occurring in persons under the age of 70. Cardiovascular disorders must be diagnosed as soon as possible so that therapy and medicine can begin, increasing the need for cardiovascular information systems. These technologies improve the productivity and efficiency of software and medical records. They are more efficient than previous ways of storing and analyzing cardiac data in patients; hence, their demand is higher.
The emergence of zero-footprint systems and data-driven technologies is anticipated to drive the Cardiovascular Information System market's expansion in the years ahead.

Key Restraints for Cardiovascular Information System Market

Risk of data breaches and stringent regulations for patient data protection
High initial expenses for product implementation and maintenance

Introduction of the Cardiovascular Information System Market

The Cardiovascular Information System (CIS) market is expanding rapidly, owing to the rising prevalence of cardiovascular diseases (CVDs), advances in healthcare information technology, and the growing demand for effective data administration in cardiology clinics. CIS are specialized electronic health record (EHR) systems that handle and streamline the massive amounts of data generated by cardiology departments. These solutions improve clinical decision-making, patient outcomes, and workflow efficiency. Additionally, Healthcare IT innovations such as cloud-based solutions, artificial intelligence (AI), and machine learning (ML) are revolutionizing CIS. These technologies improve data integration, predictive analytics, and individualized treatment regimens, resulting in increased market growth. Cardiac Information Systems help improve workflows in hospitals and cardiac departments. Improved data management, reporting, and communication among healthcare staff have a favorable impact on patient care and outcomes.

1999–2000 to 2017–2018. The National Health and Nutrition Examination Survey (NHANES) is a program of studies designed to assess the health and nutritional status of adults and children in the United States. The survey is unique in that it combines interviews and physical examinations. Indicators from this data source have been computed by personnel in CDC's Division for Heart Disease and Stroke Prevention (DHDSP). This was one of the datasets provided by the National Cardiovascular Disease Surveillance System and presented on DHDSP’s Data, Trends, and Maps online tool. This tool was retired in April of 2024 and this dataset will not be updated. Contact dhdsprequests@cdc.gov if you need assistance with data previously included in this dataset. The data can be plotted as trends and stratified by age group, sex, and race/ethnicity.

Number of deaths caused by diseases of the circulatory system, by age group and sex, 2000 to most recent year.

Snapshot img

Cardiovascular Medical Devices Market Size 2024-2028

The cardiovascular medical devices market size is forecast to increase by USD 19.08 billion at a CAGR of 7.2% between 2023 and 2028.

The market is witnessing significant growth due to the increasing prevalence of cardiac conditions such as atrial fibrillation and clogged arteries. This trend is driven by the rising number of individuals with these conditions and the growth of insurance providers covering diagnostic monitoring devices. companies in this market are focusing on innovative technologies like Al and machine learning based electrocardiogram (ECG) technology to improve the accuracy and efficiency of cardiovascular diagnosis. Surgical devices, including ECG, Holter monitors, event monitors, and implantable loop recorders, are essential tools for the early detection and treatment of cardiovascular diseases. However, the high cost of cardiovascular procedures remains a challenge for market growth. To stay competitive, companies must offer cost-effective solutions while maintaining the highest standards of quality and patient safety. This market analysis report provides a comprehensive overview of the market growth factors, business strategies, and challenges shaping the future of the cardiovascular medical devices industry.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market holds significant importance in the healthcare industry as these devices play a crucial role in diagnosing, monitoring, and treating various heart disorders. Heart diseases, including heart failure, cardiomyopathy, and stroke, are fatal conditions that pose a major health concern worldwide. According to the World Health Organization (WHO), cardiovascular diseases accounted for approximately 17.9 million deaths in 2016. Minimally invasive procedures and advanced cardiovascular devices have revolutionized the treatment landscape, offering improved patient outcomes and reduced healthcare resources. Diagnostic monitoring devices, such as ECG and Holter monitors, enable early detection and timely intervention, thereby reducing the risk of complications and mortality.
In addition, cardiology devices, including coronary artery stents and surgical devices, have significantly contributed to the advancement of cardiovascular care. For instance, coronary artery stents help in the treatment of coronary artery diseases by improving blood flow and reducing the risk of heart attacks. Artificial intelligence (AI) is increasingly being integrated into cardiovascular devices to enhance their functionality and accuracy. AL-based ECG technology, for example, can analyze ECG data more efficiently and accurately than traditional methods, enabling early detection and diagnosis of heart conditions. The cardiovascular devices market is expected to witness steady growth due to the increasing prevalence of heart disorders and the need for advanced diagnostic and therapeutic solutions.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Diagnostic and monitoring systems
  Surgical devices


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France
    Italy


  Asia

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Product Insights

The diagnostic and monitoring systems segment is estimated to witness significant growth during the forecast period.

The diagnostic and monitoring segment of the international market comprises various devices that play a vital role in evaluating heart health, identifying cardiovascular diseases (CVDs) in their initial stages, and tracking disease progression or treatment response. This segment includes devices like ECGs, which measure the electrical activity of the heart and are crucial for diagnosing arrhythmias, heart attacks, and other cardiac conditions. Furthermore, echocardiograms, which employ ultrasound technology to generate detailed images of the heart, aid in assessing structural heart diseases and evaluating heart function. Portable ECG devices, such as Holter monitors and event monitors, are also part of this segment. These devices enable continuous heart monitoring over extended durations, allowing doctors to detect irregularities that may not surface during routine ECG tests.

Get a glance at the market report of share of various segments Request Free Sample

The diagnostic and monitoring systems segment was valued at USD 21.14 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 38% to the growth of the global market during the fore

The dataset contains risk-adjusted mortality rates, quality ratings, and number of deaths and cases for 6 medical conditions treated (Acute Stroke, Acute Myocardial Infarction, Heart Failure, Gastrointestinal Hemorrhage, Hip Fracture and Pneumonia) and 3 procedures performed (Carotid Endarterectomy, Pancreatic Resection, and Percutaneous Coronary Intervention) in California hospitals. The 2023 IMIs were generated using AHRQ Version 2024, while previous years' IMIs were generated with older versions of AHRQ software (2022 IMIs by Version 2023, 2021 IMIs by Version 2022, 2020 IMIs by Version 2021, 2019 IMIs by Version 2020, 2016-2018 IMIs by Version 2019, 2014 and 2015 IMIs by Version 5.0, and 2012 and 2013 IMIs by Version 4.5). The differences in the statistical method employed and inclusion and exclusion criteria using different versions can lead to different results. Users should not compare trends of mortality rates over time. However, many hospitals showed consistent performance over years; “better” performing hospitals may perform better and “worse” performing hospitals may perform worse consistently across years. This dataset does not include conditions treated or procedures performed in outpatient settings. Please refer to statewide table for California overall rates: https://data.chhs.ca.gov/dataset/california-hospital-inpatient-mortality-rates-and-quality-ratings/resource/af88090e-b6f5-4f65-a7ea-d613e6569d96

As of 2022, the countries with the highest death rates worldwide were Ukraine, Bulgaria, and Moldova. In these countries, there were 17 to 21 deaths per 1,000 people. The country with the lowest death rate is Qatar, where there is just one death per 1,000 people. Leading causes of death The leading causes of death worldwide are by far, ischaemic heart disease and stroke, accounting for a combined 27 percent of all deaths in 2019. In that year, there were 8.89 million deaths worldwide from ischaemic heart disease and 6.19 million from stroke. Interestingly, a worldwide survey from that year found that people greatly underestimate the proportion of deaths caused by cardiovascular disease, but overestimate the proportion of deaths caused by suicide, interpersonal violence, and substance use disorders. Death in the United States In 2022, there were around 3.27 million deaths in the United States. The leading causes of death in the United States are currently heart disease and cancer, accounting for a combined 40 percent of all deaths in 2022. Lung and bronchus cancer is the deadliest form of cancer worldwide, as well as in the United States. In the U.S. this form of cancer is predicted to cause around 65,790 deaths among men alone in the year 2024. Prostate cancer is the second-deadliest cancer for men in the U.S. while breast cancer is the second deadliest for women. In 2022, the fourth leading cause of death in the United States was COVID-19. Deaths due to COVID-19 resulted in a significant rise in the total number of deaths in the U.S. in 2020 and 2021 compared to 2019.

The Defibrillator market was valued at $13.16 billion in 2022 and will reach $23.1 billion by 2030, with a CAGR of 5.8% during the forecast period.

North America held the major market share for more than XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX % from 2024 to 2031. The Asia Pacific region is the fastest-growing market with a CAGR of XX% from 2024 to 2031 and it is projected that it will grow at a CAGR of XX% in the future. Europe accounted for a market share of over XX% of the global revenue with a market size of USD XX million. Latin America had a market share for more than XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031. Middle East and Africa had a market share of around XX% of the global revenue and was estimated at a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031. The Defibrillator Market held the highest market revenue share in 2024. Market Dynamics of the Defibrillator Market

Key Drivers for The Defibrillator Market

The growing senior population in emerging economies fuels, the growth of the defibrillator market 

Emerging economies are acknowledged as one of the key areas of medical device growth. The growing patient base of people with degenerative diseases, orthopedic ailments, cardiovascular diseases, and other conditions can be greatly assisted by more advanced technology-based implantable devices, particularly for conditions for which pharmaceutical treatment is effective. For instance, as per the Asia Aging International Population Reports 2022, it is anticipated that the population of those 65 years of age and over will increase from 730 million in 2020 to around 2 billion by 2060. The prevalence of chronic illnesses is rising as a result of population growth. The Centers for Disease Control and Prevention (CDC) and the National Association of Chronic Disease Directors estimate that one or more of the five chronic diseases—diabetes, cancer, heart disease, stroke, and chronic obstructive pulmonary disease—cause more than two-thirds of all fatalities. Consequently, as the population grows and the prevalence of cardiovascular disorders rises in emerging nations like Brazil and India, healthcare spending rises as well, driving up the need for defibrillators and also serves as an opportunity for the key players in emerging economies. Source:(https://www.weforum.org/agenda/2023/02/world-oldest-populations-asia-health/) Thus, the rising geriatric population in emerging economies is a significant driver for the growth of the defibrillator market. As these populations age, the incidence of cardiac-related issues increases, creating a greater demand for defibrillators in healthcare settings to address cardiac emergencies and improve patient outcomes.

Market demand for defibrillators is driven by the growing need for portable defibrillators due to the prevalence of cardiovascular diseases. 

Heart disease, stroke, peripheral vascular disease, and other cardiovascular disorders are the main causes of mortality worldwide, particularly in the United States and other industrialized nations. The primary contributing factors are obesity and its aftereffects, which include dyslipidemia, hypertension, and insulin resistance, which can result in diabetes. In 2020, 19.1 million deaths worldwide were linked to cardiovascular disease (CVD), according to the American Heart Association (AHA). Furthermore, more people die from cardiovascular illnesses annually than from all cancers combined with chronic lower respiratory ailments. Defibrillators are implanted devices that can be placed either within or outside the body to treat certain cardiac occurrences, such as arrhythmias. Ventricular tachycardia (VT) or ventricular fibrillation (VF), two types of fast, chaotic heart activity, are the primary cause of most cardiac events. If treated within minutes, most sufferers of cardiac arrest can recover; however, administering an electrical tremor is the only therapy that works. Various kinds of defibrillators are employed to manage arrhythmia and avert severe consequences. For instance, in October 2023, The FDA in the United States approved the Aurora EV-IVD MRI SureScan and Epsila EV MRI SureScan defibril...

Medical family illness assesses the presence and severity of medical problems of first degree family members, including pulmonary embolism, epilepsy, diabetes, hypertension, heart attack, stroke, migraine, cancer and miscarriage.

Preliminary figures between January to September 2024 indicated that ischaemic heart disease was the leading cause of death in the Philippines. The number of people who died from this illness was estimated at 75,500. Following this, cancer resulted in the deaths of about 43,000 people. Eating habits Heart diseases have been linked to high meat consumption, among others. In the Philippines, pork has been the most consumed meat type, followed closely by chicken. While pork meat is typically produced domestically, the country also imports pork to supplement its supply. However, plant-based food has started gaining popularity among Filipinos. In fact, a 2024 survey revealed that 69 percent of surveyed Filipinos consumed plant-based products, including meat alternatives. Common diseases in the Philippines Aside from heart and cerebrovascular diseases, the Filipino population is also exposed to infections, diabetes, skin diseases, and illnesses resulting from high meat consumption. In 2020, over 700,000 Filipinos contracted acute respiratory tract infections, followed by over 400,000 diagnosed with hypertension. In areas with high exposure to rain, dengue infections and leptospirosis have also become prevalent.

It was estimated that as of 2022 around 24.4 million people in the United States had been diagnosed with diabetes. The number of people diagnosed with diabetes in the U.S. has increased in recent years and the disease is now a major health issue. Diabetes is now the eighth leading cause of death in the United States, accounting for three percent of all deaths.

What is prediabetes? A person is considered to have prediabetes if their blood sugar levels are higher than normal but not high enough to be diagnosed with type 2 diabetes. As of 2021, it was estimated that around 53 million men and 44 million women in the United States had prediabetes. However, according to the CDC, around 80 percent of these people do not know they have this condition. Not only does prediabetes increase the risk of developing type 2 diabetes, but also increases the risk of heart disease and stroke. The states with the highest share of adults who had ever been told they have prediabetes are Hawaii, California, and Alaska.

The prevalence of diabetes in the United States As of 2022, around 8.4 percent of adults in the United States had been diagnosed with diabetes, an increase from six percent in the year 2000. Diabetes is much more common among older adults, with almost a quarter of those aged 65 years and older diagnosed with diabetes, compared to just three percent of those aged 18 to 44 years. The states with the highest prevalence of diabetes among adults are Alabama, Mississippi, and West Virginia, while Colorado and Alaska report the lowest rates. In Alabama, around 17 percent of adults have been diagnosed with diabetes.